Hana Pharm Co Ltd Cash Flow Reinvestment Rate
Hana Pharm Co Ltd cash flow reinvestment rate. Hana Pharm Co Ltd (293480) has a Cash Flow Reinvestment Rate of 5.84x as of June 2026, reinvesting ₩40.35 Billion (capex ₩17.59 Billion plus investments ₩22.76 Billion) from operating cash flow of ₩6.91 Billion. Explore 293480 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hana Pharm Co Ltd (2016–2025)
Cash flow reinvestment rate of Hana Pharm Co Ltd from 2016 to 2025. Historical reinvestment intensity for Hana Pharm Co Ltd across 10 annual periods. Explore 293480 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Hana Pharm Co Ltd Cash Flow Reinvestment Rate by Year (2016–2025)
Hana Pharm Co Ltd cash flow reinvestment rate by year from 2016 to 2025. Year-by-year capital reinvestment analysis for Hana Pharm Co Ltd. For the full cash flow conversion analysis, see 293480 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.40x | ₩31.19 Billion | ₩9.18 Billion | ₩31.18 Billion | ▲ +501.3% |
| 2024 | 0.57x | ₩14.30 Billion | ₩25.30 Billion | ₩13.21 Billion | ▼ -60.9% |
| 2023 | 1.44x | ₩26.58 Billion | ₩18.40 Billion | ₩14.68 Billion | ▼ -38.3% |
| 2022 | 2.34x | ₩72.28 Billion | ₩30.88 Billion | ₩35.77 Billion | ▼ -14.6% |
| 2021 | 2.74x | ₩70.31 Billion | ₩25.66 Billion | ₩34.81 Billion | ▲ +137.4% |
| 2020 | 1.15x | ₩17.98 Billion | ₩15.58 Billion | ₩17.14 Billion | ▼ -30.7% |
| 2019 | 1.66x | ₩52.79 Billion | ₩31.72 Billion | ₩33.73 Billion | ▼ -55.6% |
| 2018 | 3.75x | ₩103.50 Billion | ₩27.59 Billion | ₩5.57 Billion | ▲ +691.2% |
| 2017 | 0.47x | ₩12.04 Billion | ₩25.38 Billion | ₩10.19 Billion | ▼ -36.3% |
| 2016 | 0.74x | ₩9.27 Billion | ₩12.46 Billion | ₩8.31 Billion | — |